Loren Rourke, MD
Surgical Oncology · Shenandoah, TXNPI 1336343235
Payments from drug & device makers
Across 53 payments — averaging $88.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Axogen$1K
- GE HealthCare$1K
- Tempus AI, Inc$282
- Myriad Genetic Laboratories, Inc.$131
- Genentech USA, Inc.$81
- plus $524 from 17 others
What the payments were for
- Speaking & faculty fees$1,27527%
- Travel & lodging$1,70036%
- Food & beverage$1,68536%
- Education$130%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 3 | $1,326 |
| Axogen | 9 | $1,274 |
| GE HealthCare | 6 | $1,053 |
| Tempus AI, Inc | 8 | $282 |
| Myriad Genetic Laboratories, Inc. | 6 | $131 |
| Genentech USA, Inc. | 1 | $81 |
| Regeneron Healthcare Solutions, Inc. | 2 | $49 |
| AbbVie | 1 | $49 |
| Endomagnetics Ltd | 1 | $48 |
| Biotissue Holdings Inc. | 1 | $46 |
| Merck | 2 | $44 |
| Johnson & Johnson | 2 | $38 |
| Lilly USA, LLC | 1 | $35 |
| Pharmacosmos Therapeutics Inc. | 1 | $28 |
| Hologic Sales And Service, LLC | 1 | $27 |
| Incyte Corporation | 1 | $27 |
| Novocure Inc. | 1 | $26 |
| Stryker | 1 | $23 |
| Vertex | 1 | $21 |
| Elucent Medical | 1 | $19 |
| Puma Biotechnology, Inc. | 1 | $18 |
| Coopersurgical, Inc. | 1 | $15 |
| AstraZeneca | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PlasmaBlade$1,275
- AVANCE NERVE GRAFT$1,183
- AxoGuard Nerve Connector$1,183
- AxoGuard Nerve Protector$1,183
- AXOGUARD HA+ NERVE PROTECTOR$1,183
- AxoGuard Nerve Cap$1,183
- XT CDX$123
How this compares
$4,672 in reported general payments places this provider in the 65th percentile of 191 surgical oncology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgical oncology in Shenandoah
- John HardawayShenandoah$164K
- Diana HookShenandoah$5K
- Jennifer WargoHouston$6M
- Ernest CampHouston$3.6M
- Hop Tran CaoHouston$928K
- Elizabeth GrubbsHouston$750K
- Alastair ThompsonHouston$568K
- Merrick RossHouston$283K
- Adam YoppDallas$281K
- Allison DipasqualeDallas$272K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.